Skip to content Skip to footer
Erelzi: Benefits, Reviews, Info, Side Effects!
Rx Details
Erelzi
Etanercept biosimilar, TNF inhibitor
Etanercept
Prescription
Biologic
Drugs
Biological Product
biosimilar to Enbrel, treats rheumatoid arthritis, treats psoriatic arthritis, treats ankylosing spondylitis, treats plaque psoriasis, treats juvenile idiopathic arthritis, reduces inflammation, improves joint function
Abdominal Pain, Anemia, Back Pain, Cough, Diarrhea, Dizziness, Elevated Liver Enzymes, Fatigue, Headache, Hypertension, Injection Site Reactions, Leukopenia, Nausea, Neutropenia, Pruritus, Rash, Sinusitis, Upper Respiratory Infections
Erelzi is a biosimilar to Enbrel (etanercept) and is used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. The dosage of Erelzi can vary depending on the specific condition being treated and the patient’s response to the medication. For adults with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, the typical dosage is 50 mg administered once weekly. For plaque psoriasis, the initial dosage might be 50 mg twice weekly for the first 3 months, followed by 50 mg once weekly. It’s important to note that the exact dosage and administration schedule should be determined by a healthcare professional based on individual patient needs and medical history. Always consult with a healthcare provider for personalized dosing information.
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, juvenile idiopathic arthritis
Erelzi has a generally favorable safety profile.
Methotrexate, adalimumab, etanercept, infliximab, corticosteroids
$1,000 – $1,500
$5,000

A Synopsis of

Erelzi

Erelzi is a medication that falls under the category of biosimilars, which are drugs that are highly similar to already approved biologic medications. It is used to treat various inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.

Erelzi works by targeting a specific protein in the body called tumor necrosis factor (TNF), which plays a key role in the inflammatory response. By blocking TNF, Erelzi helps to reduce inflammation and alleviate symptoms such as joint pain, swelling, and stiffness.

It is important to note that Erelzi should only be used under the guidance of a healthcare provider, as it is a prescription medication that requires careful monitoring and supervision. Your doctor will determine the appropriate dosage and frequency of Erelzi based on your specific condition and medical history.

As with any medication, Erelzi may cause side effects in some individuals. Common side effects may include injection site reactions, infections, and gastrointestinal issues. It is important to report any side effects to your healthcare provider promptly.

Overall, Erelzi has been shown to be an effective treatment option for many patients with inflammatory conditions. If you have been prescribed Erelzi, be sure to follow your doctor’s instructions carefully and attend all follow-up appointments to monitor your progress. By working closely with your healthcare team, you can help manage your condition and improve your quality of life.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN